Cargando…

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

The capacity of antibodies to engage with immune cells via the Fc region is important in preventing and controlling many infectious diseases. The evolution of such antibodies during convalescence from coronavirus disease 2019 (COVID-19) is largely unknown. We develop assays to measure Fc-dependent a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wen Shi, Selva, Kevin John, Davis, Samantha K., Wines, Bruce D., Reynaldi, Arnold, Esterbauer, Robyn, Kelly, Hannah G., Haycroft, Ebene R., Tan, Hyon-Xhi, Juno, Jennifer A., Wheatley, Adam K., Hogarth, P. Mark, Cromer, Deborah, Davenport, Miles P., Chung, Amy W., Kent, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106889/ https://www.ncbi.nlm.nih.gov/pubmed/33997824 http://dx.doi.org/10.1016/j.xcrm.2021.100296

Ejemplares similares

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
por: Selva, Kevin J., et al.
Publicado: (2023)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
por: Haycroft, Ebene R., et al.
Publicado: (2023)

Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice
por: Tan, Hyon-Xhi, et al.
Publicado: (2019)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
por: Kent, Stephen J., et al.
Publicado: (2022)

Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions
por: Lopez, Ester, et al.
Publicado: (2019)

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
por: Wheatley, Adam K., et al.
Publicado: (2021)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem
por: Tan, Hyon-Xhi, et al.
Publicado: (2019)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Tan, Hyon-Xhi, et al.
Publicado: (2021)

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019)

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Liu, Yi, et al.
Publicado: (2019)

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field
por: Wines, Bruce D., et al.
Publicado: (2017)

Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem
por: Jiang, Wenbo, et al.
Publicado: (2020)

Antibody glycosylation correlates with disease progression in SIV‐ Mycobacterium tuberculosis coinfected cynomolgus macaques
por: Haycroft, Ebene R, et al.
Publicado: (2023)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
por: Davis, Samantha K, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
por: Koutsakos, Marios, et al.
Publicado: (2023)

Interplay of infection and vaccination in long-term protection from COVID-19
por: Tan, Hyon-Xhi, et al.
Publicado: (2022)

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2023)

Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption
por: Billings, Hugh, et al.
Publicado: (2019)

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
por: Pilapitiya, Devaki, et al.
Publicado: (2023)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
por: Wines, Bruce D., et al.
Publicado: (2021)

Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
por: Chenoweth, Alicia M, et al.
Publicado: (2020)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells
por: Jiang, Wenbo, et al.
Publicado: (2021)

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
por: Wines, Bruce D., et al.
Publicado: (2022)

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
por: Wines, Bruce D., et al.
Publicado: (2023)

Serum IgA Fc effector functions in infectious disease and cancer
por: Davis, Samantha K, et al.
Publicado: (2020)

Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
por: Lopez, Ester, et al.
Publicado: (2021)

Sequencing B cell receptors from ferrets (Mustela putorius furo)
por: Wong, Julius, et al.
Publicado: (2020)

Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure
por: Parsons, Matthew S., et al.
Publicado: (2021)

Adaptive immunity to human coronaviruses is widespread but low in magnitude
por: Tan, Hyon‐Xhi, et al.
Publicado: (2021)

A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination
por: Lemke, Melissa M., et al.
Publicado: (2021)

Dimeric FcγR ectodomains detect pathogenic anti‐platelet factor 4–heparin antibodies in heparin‐induced thromobocytopenia
por: Wines, B. D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rjkp4a2bjc54t911hgeust1hdd